Role of mitochondrial dysfunction and dysregulation of Ca2+ homeostasis in insulin insensitivity of mammalian cells

Annals of the New York Academy of Sciences

Volumn 1350, Issue 1, 2015, Pages 66-76

  Wang, Chih Hao ^a   Tsai, Ting Fen ^a,b   Wei, Yau Huei ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

Ca2+ homeostasis; insulin insensitivity; mitochondria associated ER membranes; mitochondrial dysfunction; type 2 diabetes

Indexed keywords

ADIPONECTIN;

ADIPOCYTE; ARTICLE; BIOENERGY; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL DIFFERENTIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM MEMBRANE; GENETIC TRANSCRIPTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; SIGNAL TRANSDUCTION;

EID: 84937862938     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12838     Document Type: Article

References (73)

1. Rother, K.I. 2007. Diabetes treatment–bridging the divide. N. Engl. J. Med. 356: 1499–1501.
2. Taniguchi, C.M., B. Emanuelli & C.R. Kahn. 2006. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7: 85–96.
3. Wang, C.H., C.C. Wang & Y.H. Wei. 2010. Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. Ann. N.Y. Acad. Sci. 1201: 157–165.
4. Martin, S.D. & S.L. McGee. 2014. The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes. Biochim. Biophys. Acta 1840: 1303–1312.
5. Heinonen, S., J. Buzkova, M. Muniandy, et al. 2015. Impaired mitochondrial biogenesis in adipose tissue in acquired obesity. Diabetes DOI: 10.2337/db14-1937.
6. Schmid, A.I., J. Szendroedi, M. Chmelik, et al. 2011. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 34: 448–453.
7. vanTienen, F.H., S.F. Praet, H.M. deFeyter, et al. 2012. Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes. J. Clin. Endocrinol. Metab. 97: 3261–3269.
8. Sutherland, L.N., L.C. Capozzi, N.J. Turchinsky, et al. 2008. Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance. Am. J. Physiol. Endocrinol. Metabol. 295: E1076–1083.
9. Gong, Y.Y., Y.Y. Liu, J. Li, et al. 2014. Hypermethylation of Cox5a promoter is associated with mitochondrial dysfunction in skeletal muscle of high fat diet-induced insulin resistant rats. PLoS One 9: e113784.
10. Chen, L.L., H.H. Zhang, J. Zheng, et al. 2011. Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial beta-oxidation. Metabolism 60: 1598–1609.
11. Rong, J.X., Y. Qiu, M.K. Hansen, et al. 2007. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 56: 1751–1760.
12. Liu, R., P. Jin, L. Yu, et al. 2014. Impaired mitochondrial dynamics and bioenergetics in diabetic skeletal muscle. PLoS One 9: e92810.
13. Lu, H., V. Koshkin, E.M. Allister, et al. 2010. Molecular and metabolic evidence for mitochondrial defects associated with beta-cell dysfunction in a mouse model of type 2 diabetes. Diabetes 59: 448–459.
14. Wang, C.H., C.C. Wang, H.C. Huang, et al. 2013. Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes. FEBS J. 280: 1039–1050.
15. Chen, Y.F., C.H. Kao, Y.T. Chen, et al. 2009. Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev. 23: 1183–1194.
16. 2+ homeostasis. Hum. Mol. Genet. 23: 4770–4785.
17. Rimessi, A., C. Giorgi, P. Pinton, et al. 2008. The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death. Biochim. Biophys. Acta 1777: 808–816.
18. Marchi, S. & P. Pinton. 2014. The mitochondrial calcium uniporter complex: molecular components, structure and physiopathological implications. J. Physiol. 592: 829–839.
19. 2+ uniporter complex. J. Mol. Cell. Cardiol. 78: 3–8.
20. 2+ exchanger. J. Biol. Chem. 287: 31650–31657.
21. Halestrap, A.P. & A.P. Richardson. 2015. The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury. J. Mol. Cell. Cardiol. 78: 129–141.
22. 2+. Cell Calcium 52: 28–35.
23. Carafoli, E. 2010. The fateful encounter of mitochondria with calcium: how did it happen? Biochim. Biophys. Acta 1797: 595–606.
24. 2+ signals. EMBO J. 18: 4999–5008.
25. Duchen, M.R., A. Verkhratsky & S. Muallem. 2008. Mitochondria and calcium in health and disease. Cell Calcium 44: 1–5.
26. Parone, P.A., S. Da Cruz, J.S. Han, et al. 2013. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. J. Neurosci. 33: 4657–4671.
27. Ozcan, L., J. Cristina de Souza, A.A. Harari, et al. 2013. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling. Cell Metab. 18: 803–815.
28. Yamaguchi, T., I. Kanazawa, S. Takaoka, et al. 2011. Serum calcium is positively correlated with fasting plasma glucose and insulin resistance, independent of parathyroid hormone, in male patients with type 2 diabetes mellitus. Metabolism 60: 1334–1339.
29. 2+ in high-fat-fed rats. Metabolism 51: 912–918.
30. Kennedy, A., K. Martinez, S. Chung, et al. 2010. Inflammation and insulin resistance induced by trans-10, cis-12 conjugated linoleic acid depend on intracellular calcium levels in primary cultures of human adipocytes. J. Lipid Res. 51: 1906–1917.
31. Yang, C., R.T. Watson, J.S. Elmendorf, et al. 2000. Calmodulin antagonists inhibit insulin-stimulated GLUT4 (glucose transporter 4) translocation by preventing the formation of phosphatidylinositol 3,4,5-trisphosphate in 3T3L1 adipocytes. Mol. Endocrinol. 14: 317–326.
32. 3 receptor pathway is required for insulin-stimulated glucose transporter 4 translocation and glucose uptake in cardiomyocytes. Endocrinology 151: 4665–4677.
33. 2+ influx for insulin-mediated glucose uptake in skeletal muscle. Diabetes 55: 2077–2083.
34. Li, Y., P. Wang, J. Xu, et al. 2007. Regulation of insulin secretion and GLUT4 trafficking by the calcium sensor synaptotagmin VII. Biochem. Biophys. Res. Commun. 362: 658–664.
35. Bose, A., A. Guilherme, S.I. Robida, et al. 2002. Glucose transporter recycling in response to insulin is facilitated by myosin Myo1c. Nature 420: 821–824.
36. Chen, X.W., D. Leto, S.H. Chiang, et al. 2007. Activation of RalA is required for insulin-stimulated Glut4 trafficking to the plasma membrane via the exocyst and the motor protein Myo1c. Dev. Cell 13: 391–404.
37. Yip, M.F., G. Ramm, M. Larance, et al. 2008. CaMKII-mediated phosphorylation of the myosin motor Myo1c is required for insulin-stimulated GLUT4 translocation in adipocytes. Cell Metab. 8: 384–398.
38. Wang, C., Y. Chi, J. Li, et al. 2014. FAM3A activates PI3K p110alpha/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis. Hepatology 59: 1779–1790.
39. Maechler, P. & C.B. Wollheim. 2001. Mitochondrial function in normal and diabetic beta-cells. Nature 414: 807–812.
40. Rieusset, J. 2011. Mitochondria and endoplasmic reticulum: mitochondria-endoplasmic reticulum interplay in type 2 diabetes pathophysiology. Int. J. Biochem. Cell Biol. 43: 1257–1262.
41. 2+ uniporter (MCU) contribute to metabolism-secretion coupling in clonal pancreatic beta-cells. J. Biol. Chem. 287: 34445–34454.
42. 2+ uniporter in the generation of mitochondrial pH gradient and metabolism-secretion coupling in insulin-releasing cells. J. Biol. Chem. 290: 4086–4096.
43. Jensen, B., M.C. Farach-Carson, E. Kenaley, et al. 2004. High extracellular calcium attenuates adipogenesis in 3T3-L1 preadipocytes. Exp. Cell Res. 301: 280–292.
44. Liu, L. & N.A. Clipstone. 2007. Prostaglandin F2α inhibits adipocyte differentiation via a Gαq-calcium-calcineurin-dependent signaling pathway. J. Cell. Biochem. 100: 161–173.
45. Zhang, L.L., D. Yan Liu, L.Q. Ma, et al. 2007. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ. Res. 100: 1063–1070.
46. 2+ in the early stages of murine adipocyte differentiation as evidenced by calcium mobilizing agents. Differentiation 60: 151–158.
47. Neal, J.W. & N.A. Clipstone. 2002. Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1 cells. J. Biol. Chem. 277: 49776–49781.
48. 2+/calmodulin-dependent protein kinase kinase, CaMKK2, inhibits preadipocyte differentiation. Endocrinology 152: 3668–3679.
49. Szabo, E., Y. Qiu, S. Baksh, et al. 2008. Calreticulin inhibits commitment to adipocyte differentiation. J. Cell Biol. 182: 103–116.
50. Dyck, D.J. 2009. Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl. Physiol. Nutr. Metab. 34: 396–402.
51. Yamauchi, T., J. Kamon, H. Waki, et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7: 941–946.
52. Yamauchi, T., J. Kamon, Y. Minokoshi, et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8: 1288–1295.
53. 2+ and AMPK/SIRT1. Nature 464: 1313–1319.
54. Sharma, N.K., S.K. Das, A.K. Mondal, et al. 2008. Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. J. Clin. Endocrinol. Metab. 93: 4532–4541.
55. Boden, G., X. Duan, C. Homko, et al. 2008. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 57: 2438–2444.
56. Yang, J., N. Ao, J. Du, et al. 2015. Protective effect of liraglutide against ER stress in the liver of high-fat diet-induced insulin-resistant rats. Endocrine 49: 106–118.
57. Ozcan, U., Q. Cao, E. Yilmaz, et al. 2004. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457–461.
58. Wang, H., R.Q. Sun, X.Y. Zeng, et al. 2015. Restoration of autophagy alleviates hepatic ER stress and impaired insulin signalling transduction in high fructose-fed male mice. Endocrinology 156: 169–181.
59. Pardo, V., A. Gonzalez-Rodriguez, J. Muntane, et al. 2015. Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection. Food Chem. Toxicol. 80: 298–309.
60. Li, H., B. Zhou, J. Liu, et al. 2015. Administration of progranulin (PGRN) triggers ER stress and impairs insulin sensitivity via PERK-eIF2alpha-dependent manner. Cell Cycle 14: 1893–1907.
61. Nakatani, Y., H. Kaneto, D. Kawamori, et al. 2005. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 280: 847–851.
62. Ozcan, U., E. Yilmaz, L. Ozcan, et al. 2006. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313: 1137–1140.
63. Patergnani, S., J.M. Suski, C. Agnoletto, et al. 2011. Calcium signaling around mitochondria-associated membranes (MAMs). Cell Commun. Signal. 9: 19.
64. Csordas, G., C. Renken, P. Varnai, et al. 2006. Structural and functional features and significance of the physical linkage between ER and mitochondria. J. Cell Biol. 174: 915–921.
65. 2+ signaling units. Adv. Exp. Med. Biol. 740: 411–437.
66. Walter, L. & G. Hajnoczky. 2005. Mitochondria and endoplasmic reticulum: the lethal interorganelle cross-talk. J. Bioenerg. Biomembr. 37: 191–206.
67. Leem, J. & E.H. Koh. 2012. Interaction between mitochondria and the endoplasmic reticulum: implications for the pathogenesis of type 2 diabetes mellitus. Exp. Diabetes Res. 2012: 242984.
68. Hedskog, L., C.M. Pinho, R. Filadi, et al. 2013. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc. Natl. Acad. Sci. USA 110: 7916–7921.
69. Piccini, M., F. Vitelli, M. Bruttini, et al. 1998. FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation. Genomics 47: 350–358.
70. Stone, S.J. & J.E. Vance. 2000. Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes. J. Biol. Chem. 275: 34534–34540.
71. Chang, N.C., M. Nguyen, J. Bourdon, et al. 2012. Bcl-2-associated autophagy regulator Naf-1 required for maintenance of skeletal muscle. Hum. Mol. Genet. 21: 2277–2287.
72. Arruda, A.P., B.M. Pers, G. Parlakgul, et al. 2014. Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat. Med. 20: 1427–1435.
73. Tubbs, E., P. Theurey, G. Vial, et al. 2014. Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance. Diabetes 63: 3279–3294.